Argentina Medicinal Products Export Market -- HS Code 300490 Trade Data & Price Trend (Apr 2025)

Argentina's Medicinal Products (HS Code 300490) export in April 2025 hit $86.56M, with Turkey as the premium market and Uruguay/Brazil driving volume. Data from yTrade.

Argentina Medicinal Products Export (HS 300490) Key Takeaways

Argentina's Medicinal Products export under HS Code 300490 in April 2025 shows a high-value product mix, with premium sub-codes like 30049069990 driving 39.46% of export value despite lower volume. The market is stabilizing after March’s price surge, with April’s $86.56 million export value reflecting normalized demand. Turkey dominates as the premium destination, accounting for 21.59% of value at exceptionally high unit prices, while Uruguay and Brazil absorb bulk volume at lower margins. This analysis covers April 2025 and is based on processed Customs data from the yTrade database.

Argentina Medicinal Products Export (HS 300490) Background

What is HS Code 300490?

HS Code 300490 covers medicaments, mixed or unmixed, for therapeutic or prophylactic uses. These products are critical for healthcare systems worldwide, driving stable global demand due to their essential role in treatment and disease prevention. The pharmaceutical and medical industries are the primary consumers, ensuring consistent trade activity under this classification.

Current Context and Strategic Position

While no specific trade policy updates have been announced, Argentina's medicinal products export sector remains strategically significant. The country is a key supplier of pharmaceutical ingredients and finished medicaments, leveraging its robust production capabilities. Monitoring hs code 300490 trade data is vital, as shifts in global demand or local regulatory changes could impact Argentina's export dynamics. Vigilance is particularly important given the sector's contribution to the national economy and its role in global supply chains.

Argentina Medicinal Products Export (HS 300490) Price Trend

Key Observations

Argentina's Medicinal Products exports under HS code 300490 reached $86.56 million in April 2025, with shipment volume totaling 1.03 million kilograms. This represents a significant month-over-month decline in export value from March's $322.38 million, though April's volume was the highest in the observed period.

Price and Volume Dynamics

The Argentina Medicinal Products Export trend showed remarkable volatility in early 2025. While export volume remained relatively stable between 879,000-966,000 kg in January-February, March witnessed an extraordinary price surge to $354.64/kg that drove values to $322 million despite slightly lower volume. The subsequent April correction to $83.78/kg, coupled with the highest monthly volume, suggests the March spike may have reflected atypical bulk shipments or contract timing rather than sustained pricing. The hs code 300490 value trend appears to be normalizing toward more historical levels, with the sequential volume increase in April potentially indicating responsive production to global demand cycles. This pattern aligns with typical pharmaceutical export behavior where quarterly contract fulfillments and active ingredient shipment timing can create temporary distortions before markets rebalance.

Argentina Medicinal Products Export (HS 300490) HS Code Breakdown

Product Specialization and Concentration

In April 2025, Argentina's export of medicinal products under HS Code 300490 is highly concentrated, with sub-code 30049069990 dominating the market. According to yTrade data, this sub-code holds a 39.46% value share despite a 19.18% quantity share, indicating a higher unit price of 4.98 USD per unit, which suggests a focus on specialized or premium medicaments packaged for retail sale. The analysis period shows no extreme price anomalies that require isolation, as all sub-codes fall within a reasonable range.

Value-Chain Structure and Grade Analysis

The remaining sub-codes can be grouped into three categories based on unit price, reflecting different quality grades or formulations. High-value products include those with unit prices above 5 USD, such as 30049059900 and 30049069919, which likely represent advanced or niche medicaments. Mid-range products, like 30049079990 and 30049039900 with prices between 2 and 5 USD, indicate standard finished goods. Low-end products, such as 30049049900 and 30049024100 with prices below 2 USD, suggest more basic or bulk-like offerings, though all are packaged for retail, pointing to a trade in differentiated manufactured goods rather than fungible commodities.

Strategic Implication and Pricing Power

This structure implies that exporters under Argentina's HS Code 300490 have varied pricing power, with opportunities to leverage high-value sub-codes for better margins. Strategic focus should prioritize expanding the high-end segment, as analysis of HS Code 300490 trade data shows it drives disproportionate value, while monitoring cost efficiency for lower-priced lines to maintain competitiveness in global markets.

Check Detailed HS Code 300490 Breakdown

Argentina Medicinal Products Export (HS 300490) Destination Countries

Geographic Concentration and Dominant Role

Turkey is the dominant destination for Argentina's Medicinal Products exports in April 2025, accounting for 21.59% of the total export value. This high value share is paired with a very low quantity share of just 0.02%, indicating Turkey is paying a premium price per unit. This pattern suggests strong demand for high-grade or finished pharmaceutical goods from Argentina, rather than bulk raw materials.

Destination Countries Clusters and Underlying Causes

The top destinations form three clear clusters. The High-Yield Cluster, led by Turkey, imports high-value, low-volume finished medicines. The Volume Cluster includes Uruguay and Brazil; Uruguay has a 26.09% quantity share but only a 12.03% value share, pointing to large-volume purchases of more basic or intermediate medicinal goods. The Transactional Cluster features Paraguay and Ecuador, which have high shipment frequencies (14.68% and 8.48% respectively) relative to their value shares. This implies a trade pattern of frequent, smaller shipments, likely to meet regular pharmaceutical supply chain needs or retail distribution.

Forward Strategy and Supply Chain Implications

For Argentina's Medicinal Products export strategy, the priority should be to maintain its premium position in the Turkish market. Logistics can be optimized for the high-volume trade with partners like Uruguay and Brazil, potentially consolidating shipments to reduce costs. For the high-frequency partners, supply chain reliability is key to support their regular procurement cycles. No specific trade news or policy was announced to influence these patterns.

Table: Argentina Medicinal Products (HS 300490) Top Destination Countries (Source: yTrade)

CountryValueQuantityFrequencyWeight
TURKEY15.45M4.58K8.001.58K
URUGUAY8.61M7.76M515.00135.59K
BRAZIL6.18M2.91M127.00302.26K
CHILE4.65M3.14M175.0091.79K
COLOMBIA4.50M1.20M147.0060.08K
ECUADOR************************

Get Complete Destination Countries Profile

Action Plan for Medicinal Products Market Operation and Expansion

  • Prioritize expanding high-value sub-codes like 30049069990 in premium markets such as Turkey, using hs code 300490 trade data to target buyers paying a premium per unit, because this directly increases profit margins for Argentina's Medicinal Products export.
  • Optimize the Medicinal Products supply chain for high-volume partners like Uruguay and Brazil by consolidating shipments, as this reduces per-unit logistics costs for large-quantity, lower-margin orders.
  • Ensure supply chain reliability for high-frequency destinations like Paraguay and Ecuador by aligning production with their regular procurement cycles, to secure recurring revenue and strengthen trade relationships.
  • Continuously analyze unit price trends within the hs code 300490 trade data to shift export composition toward higher-value products, protecting Argentina's Medicinal Products export from competing on cost alone in volatile markets.

Take Action Now —— Explore Argentina Medicinal Products Export Data

Frequently Asked Questions

Q1. What is driving the recent changes in Argentina Medicinal Products Export 2025 April?

The April 2025 export value dropped sharply to $86.56 million from March's $322.38 million, despite higher shipment volume. This reflects a normalization after March's atypical price surge, likely due to contract timing or bulk shipments rather than sustained market shifts.

Q2. Who are the main destination countries of Argentina Medicinal Products (HS Code 300490) 2025 April?

Turkey dominates with a 21.59% value share, followed by Uruguay (12.03%) and Brazil. Turkey's low volume share (0.02%) indicates premium pricing, while Uruguay's 26.09% quantity share points to bulk purchases.

Q3. Why does the unit price differ across destination countries of Argentina Medicinal Products Export?

Price differences stem from product specialization: high-value sub-codes (e.g., 30049059900 at >5 USD/unit) target Turkey, while lower-priced offerings (e.g., 30049049900 below 2 USD) serve volume-driven markets like Uruguay.

Q4. What should exporters in Argentina focus on in the current Medicinal Products export market?

Prioritize high-value sub-codes (e.g., 30049069919) for premium markets like Turkey, optimize logistics for bulk trade with Uruguay/Brazil, and ensure supply chain reliability for frequent buyers like Paraguay.

Q5. What does this Argentina Medicinal Products export pattern mean for buyers in partner countries?

Turkish buyers access premium finished goods, while Uruguay/Brazil secure cost-effective bulk products. High-frequency importers (e.g., Paraguay) benefit from reliable, smaller shipments for retail distribution.

Q6. How is Medicinal Products typically used in this trade flow?

Exports consist mainly of differentiated, retail-packaged medicaments—ranging from advanced formulations (high-value) to basic offerings (low-value)—rather than bulk commodities or raw materials.

Copyright © 2026. All rights reserved.